Financials
Financial year 2025
ConverSant R&D from Zottegem, company number BE0805558967, closed financial year 2025 with a result of € 6,622 after tax. For that financial year ConverSant R&D recorded a gross margin of € 16,533 and equity of € 115,574. Compared with financial year 2024, the result moved from € 93,099 to € 6,622. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 28, 2026.
€ 115,574
▲ 6% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 6,622
▼ 93% vs 2024
Profit after tax over the fiscal year.
€ 89,807
▲ 216% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 110,574.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 2,229
▲ 256% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 12,426
▼ 67% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|
| Gross margin | € 15,248 | € 126,677 | € 16,533 | ▼ 87% |
| Profit after taxes | € 10,853 | € 93,099 | € 6,622 | ▼ 93% |
| Equity | € 15,853 | € 108,952 | € 115,574 | ▲ 6% |
| Total debts | € 10,525 | € 40,681 | € 16,150 | ▼ 60% |
| Cash | € 17,028 | € 28,414 | € 89,807 | ▲ 216% |
| Retained profit | € 10,853 | € 103,952 | € 110,574 | ▲ 6% |
| Balance sheet total | € 26,378 | € 149,633 | € 131,724 | ▼ 12% |
Key figures of ConverSant R&D, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to ConverSant R&D?
What happened at ConverSant R&D in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 6,622 (▼ 93% vs 2024). Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Zottegem. KBO
- Guillaume Goeders became a director. NBB
In short
From € 10,853 profit in 2023 to € 6,622 profit in 2025.
Paid € 33,561 in corporate taxes since 2023.
Best year ever: 2024, with € 93,099 profit.
Management
Behind ConverSant R&D is Guillaume Goeders.
Directors
According to the 2025 annual accounts
Guillaume Goeders
Director
since 2023
Establishments
Establishment units
Physical locations of this company
Elenestraat 153
9620 Zottegem
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- GOEDERS Guillaume(oprichter) 100%
Details
- Company number
- 0805.558.967
- VAT number
- BE 0805.558.967
- Registered office
- Elenestraat 153, 9620 Zottegem
- Names & denominations
- ConverSant R&D · CSRD · ConverSant
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 7 September 2023
- Peppol
- Active · Active since 11 Sept 2025
- Activities · NACE
Overige zakelijke dienstverlening, neg
Administratieve en ondersteunende activiteiten ten behoeve van kantoren
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Activiteiten van adviesbureaus op het gebied van public relations en communicatie
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering
Adviesbureaus op het gebied van public relations en communicatie
Diverse administratieve activiteiten ten behoeve van kantoren